{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:06:00Z","timestamp":1790946360219,"version":"4.1.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41581-026-01053-5","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:02:00Z","timestamp":1769677320000},"page":"347-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Potassium and the kidney"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-3571","authenticated-orcid":false,"given":"Ewout J.","family":"Hoorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arohan R.","family":"Subramanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary R.","family":"Boyd-Shiwarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"1053_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000108","volume":"43","author":"N Korolev","year":"2021","unstructured":"Korolev, N. How potassium came to be the dominant biological cation: of metabolism, chemiosmosis, and cation selectivity since the beginnings of life. Bioessays 43, e2000108 (2021).","journal-title":"Bioessays"},{"key":"1053_CR2","doi-asserted-by":"publisher","first-page":"E821","DOI":"10.1073\/pnas.1117774109","volume":"109","author":"AY Mulkidjanian","year":"2012","unstructured":"Mulkidjanian, A. Y., Bychkov, A. Y., Dibrova, D. V., Galperin, M. Y. & Koonin, E. V. Origin of first cells at terrestrial, anoxic geothermal fields. Proc. Natl Acad. Sci. USA 109, E821\u2013E830 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1053_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.femsre.2005.03.003","volume":"29","author":"MM Kuo","year":"2005","unstructured":"Kuo, M. M., Haynes, W. J., Loukin, S. H., Kung, C. & Saimi, Y. Prokaryotic K+ channels: from crystal structures to diversity. FEMS Microbiol. Rev. 29, 961\u2013985 (2005).","journal-title":"FEMS Microbiol. Rev."},{"key":"1053_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1152\/physrev.00011.2014","volume":"95","author":"BC Rossier","year":"2015","unstructured":"Rossier, B. C., Baker, M. E. & Studer, R. A. Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited. Physiol. Rev. 95, 297\u2013340 (2015).","journal-title":"Physiol. Rev."},{"key":"1053_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.semnephrol.2006.10.003","volume":"26","author":"A Sebastian","year":"2006","unstructured":"Sebastian, A., Frassetto, L. A., Sellmeyer, D. E. & Morris, R. C. Jr The evolution-informed optimal dietary potassium intake of human beings greatly exceeds current and recommended intakes. Semin. Nephrol. 26, 447\u2013453 (2006).","journal-title":"Semin. Nephrol."},{"key":"1053_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.ejcn.1600389","volume":"51","author":"SB Eaton","year":"1997","unstructured":"Eaton, S. B., Eaton, S. B. 3rd & Konner, M. J. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur. J. Clin. Nutr. 51, 207\u2013216 (1997).","journal-title":"Eur. J. Clin. Nutr."},{"key":"1053_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3945\/ajcn.112.034413","volume":"96","author":"ME Cogswell","year":"2012","unstructured":"Cogswell, M. E. et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am. J. Clin. Nutr. 96, 647\u2013657 (2012).","journal-title":"Am. J. Clin. Nutr."},{"key":"1053_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1311989","volume":"371","author":"A Mente","year":"2014","unstructured":"Mente, A. et al. Association of urinary sodium and potassium excretion with blood pressure. N. Engl. J. Med. 371, 601\u2013611 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1681\/ASN.0000000000000476","volume":"35","author":"CR Boyd-Shiwarski","year":"2024","unstructured":"Boyd-Shiwarski, C. R. & Rodan, A. R. Solitary kidney seeks potassium alkali to lower the pressure. J. Am. Soc. Nephrol. 35, 1300\u20131302 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.118.11209","volume":"73","author":"M Gritter","year":"2019","unstructured":"Gritter, M., Rotmans, J. I. & Hoorn, E. J. Role of dietary K+ in natriuresis, blood pressure reduction, cardiovascular protection, and renoprotection. Hypertension 73, 15\u201323 (2019).","journal-title":"Hypertension"},{"key":"1053_CR11","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224\u20132260 (2012).","journal-title":"Lancet"},{"key":"1053_CR12","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/S0140-6736(19)30041-8","volume":"393","author":"GBD 2017 Diet Collaborators","year":"2019","unstructured":"GBD 2017 Diet Collaborators Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 393, 1958\u20131972 (2019).","journal-title":"Lancet"},{"key":"1053_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0002-9149(76)90356-8","volume":"38","author":"GR Meneely","year":"1976","unstructured":"Meneely, G. R. & Battarbee, H. D. High sodium-low potassium environment and hypertension. Am. J. Cardiol. 38, 768\u2013785 (1976).","journal-title":"Am. J. Cardiol."},{"key":"1053_CR14","doi-asserted-by":"publisher","first-page":"F704","DOI":"10.1152\/ajprenal.00030.2009","volume":"297","author":"V Vallon","year":"2009","unstructured":"Vallon, V., Schroth, J., Lang, F., Kuhl, D. & Uchida, S. Expression and phosphorylation of the Na+-Cl\u2212 cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am. J. Physiol. Renal Physiol 297, F704\u2013F712 (2009).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cmet.2014.12.006","volume":"21","author":"AS Terker","year":"2015","unstructured":"Terker, A. S. et al. Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab. 21, 39\u201350 (2015).","journal-title":"Cell Metab."},{"key":"1053_CR16","doi-asserted-by":"publisher","first-page":"F890","DOI":"10.1152\/ajprenal.00323.2010","volume":"299","author":"G Frindt","year":"2010","unstructured":"Frindt, G. & Palmer, L. G. Effects of dietary K on cell-surface expression of renal ion channels and transporters. Am. J. Physiol. Renal Physiol 299, F890\u2013F897 (2010).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR17","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1113\/JP272504","volume":"594","author":"D Penton","year":"2016","unstructured":"Penton, D. et al. Extracellular K+ rapidly controls NaCl cotransporter phosphorylation in the native distal convoluted tubule by Cl\u2212-dependent and independent mechanisms. J. Physiol. 594, 6319\u20136331 (2016).","journal-title":"J. Physiol."},{"key":"1053_CR18","doi-asserted-by":"publisher","first-page":"F1341","DOI":"10.1152\/ajprenal.00527.2019","volume":"318","author":"CR Boyd-Shiwarski","year":"2020","unstructured":"Boyd-Shiwarski, C. R. et al. Effects of extreme potassium stress on blood pressure and renal tubular sodium transport. Am. J. Physiol. Renal Physiol 318, F1341\u2013F1356 (2020).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ki.2013.14","volume":"83","author":"MV Sorensen","year":"2013","unstructured":"Sorensen, M. V. et al. Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice. Kidney Int. 83, 811\u2013824 (2013).","journal-title":"Kidney Int."},{"key":"1053_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.120.15933","volume":"77","author":"RA Preston","year":"2021","unstructured":"Preston, R. A. et al. Thiazide-sensitive NCC (sodium-chloride cotransporter) in human metabolic syndrome: sodium sensitivity and potassium-induced natriuresis. Hypertension 77, 447\u2013460 (2021).","journal-title":"Hypertension"},{"key":"1053_CR21","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/HYPERTENSIONAHA.123.22546","volume":"81","author":"PA Welling","year":"2024","unstructured":"Welling, P. A. et al. Potassium-switch signaling pathway dictates acute blood pressure response to dietary potassium. Hypertension 81, 1044\u20131054 (2024).","journal-title":"Hypertension"},{"key":"1053_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1152\/physrev.00044.2018","volume":"100","author":"EJ Hoorn","year":"2020","unstructured":"Hoorn, E. J., Gritter, M., Cuevas, C. A. & Fenton, R. A. Regulation of the renal NaCl cotransporter and its role in potassium homeostasis. Physiol. Rev. 100, 321\u2013356 (2020).","journal-title":"Physiol. Rev."},{"key":"1053_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1515\/CCLM.2004.118","volume":"42","author":"R Grasbeck","year":"2004","unstructured":"Grasbeck, R. The evolution of the reference value concept. Clin. Chem. Lab. Med. 42, 692\u2013697 (2004).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1053_CR24","doi-asserted-by":"publisher","first-page":"F593","DOI":"10.1152\/ajprenal.00454.2003","volume":"287","author":"P Meneton","year":"2004","unstructured":"Meneton, P., Loffing, J. & Warnock, D. G. Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule. Am. J. Physiol. Renal Physiol 287, F593\u2013F601 (2004).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2013111156","volume":"26","author":"A Todkar","year":"2015","unstructured":"Todkar, A. et al. Mechanisms of renal control of potassium homeostasis in complete aldosterone deficiency. J. Am. Soc. Nephrol. 26, 425\u2013438 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/MNH.0000000000000352","volume":"26","author":"CR Boyd-Shiwarski","year":"2017","unstructured":"Boyd-Shiwarski, C. R. & Subramanya, A. R. The renal response to potassium stress: integrating past with present. Curr. Opin. Nephrol. Hypertens. 26, 411\u2013418 (2017).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1053_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49562-w","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Low potassium activation of proximal mTOR\/AKT signaling is mediated by Kir4.2. Nat. Commun. 15, 5144 (2024).","journal-title":"Nat. Commun."},{"key":"1053_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1681\/ASN.2016090935","volume":"28","author":"CA Cuevas","year":"2017","unstructured":"Cuevas, C. A. et al. Potassium sensing by renal distal tubules requires Kir4.1. J. Am. Soc. Nephrol. 28, 1814\u20131825 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.kint.2019.12.016","volume":"97","author":"D Penton","year":"2020","unstructured":"Penton, D. et al. Collecting system-specific deletion of Kcnj10 predisposes for thiazide- and low-potassium diet-induced hypokalemia. Kidney Int. 97, 1208\u20131218 (2020).","journal-title":"Kidney Int."},{"key":"1053_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111840","volume":"41","author":"AS Terker","year":"2022","unstructured":"Terker, A. S. et al. Kir4.2 mediates proximal potassium effects on glutaminase activity and kidney injury. Cell Rep. 41, 111840 (2022).","journal-title":"Cell Rep."},{"key":"1053_CR31","doi-asserted-by":"publisher","first-page":"F925","DOI":"10.1152\/ajprenal.00536.2016","volume":"312","author":"AM Weinstein","year":"2017","unstructured":"Weinstein, A. M. A mathematical model of the rat kidney: K-induced natriuresis. Am. J. Physiol. Renal Physiol 312, F925\u2013F950 (2017).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1172\/JCI110609","volume":"70","author":"JB Stokes","year":"1982","unstructured":"Stokes, J. B. Consequences of potassium recycling in the renal medulla. Effects of ion transport by the medullary thick ascending limb of Henle\u2019s loop. J. Clin. Invest. 70, 219\u2013229 (1982).","journal-title":"J. Clin. Invest."},{"key":"1053_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00424-025-03086-4","volume":"477","author":"C Keller","year":"2025","unstructured":"Keller, C., Santos, R. R., van Megen, W. H. & Loffing, J. Characterization of ROMK cellular heterogeneity along the mouse kidney thick ascending limb. Pflugers Arch. 477, 841\u2013856 (2025).","journal-title":"Pflugers Arch."},{"key":"1053_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.190992","volume":"10","author":"H Demirci","year":"2025","unstructured":"Demirci, H. et al. Distinct cell types along thick ascending limb express pathways for monovalent and divalent cation transport. JCI Insight 10, e190992 (2025).","journal-title":"JCI Insight"},{"key":"1053_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51381-y","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Structural bases for Na+-Cl\u2212 cotransporter inhibition by thiazide diuretic drugs and activation by kinases. Nat. Commun. 15, 7006 (2024).","journal-title":"Nat. Commun."},{"key":"1053_CR36","doi-asserted-by":"publisher","first-page":"ra41","DOI":"10.1126\/scisignal.2005050","volume":"7","author":"AT Piala","year":"2014","unstructured":"Piala, A. T. et al. Chloride sensing by WNK1 involves inhibition of autophosphorylation. Sci. Signal. 7, ra41 (2014).","journal-title":"Sci. Signal."},{"key":"1053_CR37","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1016\/j.cell.2022.09.042","volume":"185","author":"CR Boyd-Shiwarski","year":"2022","unstructured":"Boyd-Shiwarski, C. R. et al. WNK kinases sense molecular crowding and rescue cell volume via phase separation. Cell 185, 4488\u20134506.e20 (2022).","journal-title":"Cell"},{"key":"1053_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1091\/mbc.E17-08-0529","volume":"29","author":"CR Boyd-Shiwarski","year":"2018","unstructured":"Boyd-Shiwarski, C. R. et al. Potassium-regulated distal tubule WNK bodies are kidney-specific WNK1 dependent. Mol. Biol. Cell 29, 499\u2013509 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"1053_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1152\/physiol.00013.2024","volume":"39","author":"CR Boyd-Shiwarski","year":"2024","unstructured":"Boyd-Shiwarski, C. R., Shiwarski, D. J. & Subramanya, A. R. A new phase for WNK kinase signaling complexes as biomolecular condensates. Physiology 39, 269\u2013287 (2024).","journal-title":"Physiology"},{"key":"1053_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI188792","volume":"135","author":"CR Boyd-Shiwarski","year":"2025","unstructured":"Boyd-Shiwarski, C. R. et al. Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates. J. Clin. Invest. 135, e188792 (2025).","journal-title":"J. Clin. Invest."},{"key":"1053_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MNH.0000000000000909","volume":"32","author":"AA McDonough","year":"2023","unstructured":"McDonough, A. A. & Layton, A. T. Sex differences in renal electrolyte transport. Curr. Opin. Nephrol. Hypertens. 32, 467\u2013475 (2023).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1053_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-physiol-042222-025920","volume":"86","author":"AR Subramanya","year":"2024","unstructured":"Subramanya, A. R. & Boyd-Shiwarski, C. R. Molecular crowding: physiologic sensing and control. Annu. Rev. Physiol. 86, 429\u2013452 (2024).","journal-title":"Annu. Rev. Physiol."},{"key":"1053_CR43","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/j.celrep.2018.11.021","volume":"25","author":"T Saritas","year":"2018","unstructured":"Saritas, T. et al. Optical clearing in the kidney reveals potassium-mediated tubule remodeling. Cell Rep. 25, 2668\u20132675.e3 (2018).","journal-title":"Cell Rep."},{"key":"1053_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158498","volume":"133","author":"PR Grimm","year":"2023","unstructured":"Grimm, P. R. et al. Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure. J. Clin. Invest. 133, e158498 (2023).","journal-title":"J. Clin. Invest."},{"key":"1053_CR45","doi-asserted-by":"publisher","first-page":"F1385","DOI":"10.1152\/ajprenal.00592.2010","volume":"300","author":"JB Wade","year":"2011","unstructured":"Wade, J. B. et al. Differential regulation of ROMK (Kir1.1) in distal nephron segments by dietary potassium. Am. J. Physiol. Renal Physiol 300, F1385\u2013F1393 (2011).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR46","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1681\/ASN.0000000000000109","volume":"34","author":"B Saha","year":"2023","unstructured":"Saha, B. et al. Potassium activates mTORC2-dependent SGK1 phosphorylation to stimulate epithelial sodium channel: role in rapid renal responses to dietary potassium. J. Am. Soc. Nephrol. 34, 1019\u20131038 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00424-017-2084-x","volume":"470","author":"VN Tomilin","year":"2018","unstructured":"Tomilin, V. N., Zaika, O., Subramanya, A. R. & Pochynyuk, O. Dietary K+ and Cl\u2212 independently regulate basolateral conductance in principal and intercalated cells of the collecting duct. Pflugers Arch. 470, 339\u2013353 (2018).","journal-title":"Pflugers Arch."},{"key":"1053_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130553","volume":"5","author":"R Carrisoza-Gaytan","year":"2020","unstructured":"Carrisoza-Gaytan, R. et al. Intercalated cell BK\u03b1 subunit is required for flow-induced K+ secretion. JCI Insight 5, e130553 (2020).","journal-title":"JCI Insight"},{"key":"1053_CR49","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/ki.2015.243","volume":"88","author":"RA Preston","year":"2015","unstructured":"Preston, R. A., Afshartous, D., Rodco, R., Alonso, A. B. & Garg, D. Evidence for a gastrointestinal-renal kaliuretic signaling axis in humans. Kidney Int. 88, 1383\u20131391 (2015).","journal-title":"Kidney Int."},{"key":"1053_CR50","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1172\/JCI103890","volume":"38","author":"RD Squires","year":"1959","unstructured":"Squires, R. D. & Huth, E. J. Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J. Clin. Invest. 38, 1134\u20131148 (1959).","journal-title":"J. Clin. Invest."},{"key":"1053_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","volume":"97","author":"CM Clase","year":"2020","unstructured":"Clase, C. M. et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 97, 42\u201361 (2020).","journal-title":"Kidney Int."},{"key":"1053_CR52","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/bmj.286.6372.1189","volume":"286","author":"B Paice","year":"1983","unstructured":"Paice, B., Gray, J. M., McBride, D., Donnelly, T. & Lawson, D. H. Hyperkalaemia in patients in hospital. Br. Med. J. 286, 1189\u20131192 (1983).","journal-title":"Br. Med. J."},{"key":"1053_CR53","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1681\/ASN.2016121344","volume":"28","author":"JR Montford","year":"2017","unstructured":"Montford, J. R. & Linas, S. How dangerous is hyperkalemia? J. Am. Soc. Nephrol. 28, 3155\u20133165 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR54","first-page":"112","volume":"7","author":"W Cremer","year":"1977","unstructured":"Cremer, W. & Bock, K. D. Symptoms and course of chronic hypokalemic nephropathy in man. Clin. Nephrol. 7, 112\u2013119 (1977).","journal-title":"Clin. Nephrol."},{"key":"1053_CR55","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00467-022-05494-5","volume":"37","author":"M Wieers","year":"2022","unstructured":"Wieers, M., Mulder, J., Rotmans, J. I. & Hoorn, E. J. Potassium and the kidney: a reciprocal relationship with clinical relevance. Pediatr. Nephrol. 37, 2245\u20132254 (2022).","journal-title":"Pediatr. Nephrol."},{"key":"1053_CR56","doi-asserted-by":"publisher","first-page":"F292","DOI":"10.1152\/ajprenal.00464.2018","volume":"316","author":"MN Thomson","year":"2019","unstructured":"Thomson, M. N. et al. Patients with hypokalemia develop WNK bodies in the distal convoluted tubule of the kidney. Am. J. Physiol. Renal Physiol 316, F292\u2013F300 (2019).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR57","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.kint.2019.09.010","volume":"97","author":"S Kudose","year":"2020","unstructured":"Kudose, S., Dounis, H. & D\u2019Agati, V. D. Multicellular vacuoles in hypokalemic nephropathy. Kidney Int. 97, 618 (2020).","journal-title":"Kidney Int."},{"key":"1053_CR58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/qjmed\/hcr095","volume":"104","author":"SB Walsh","year":"2011","unstructured":"Walsh, S. B., Unwin, E., Vargas-Poussou, R., Houillier, P. & Unwin, R. Does hypokalaemia cause nephropathy? An observational study of renal function in patients with Bartter or Gitelman syndrome. QJM 104, 939\u2013944 (2011).","journal-title":"QJM"},{"key":"1053_CR59","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1172\/JCI112973","volume":"79","author":"JP Tolins","year":"1987","unstructured":"Tolins, J. P., Hostetter, M. K. & Hostetter, T. H. Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J. Clin. Invest. 79, 1447\u20131458 (1987).","journal-title":"J. Clin. Invest."},{"key":"1053_CR60","doi-asserted-by":"publisher","first-page":"F620","DOI":"10.1152\/ajprenal.2001.281.4.F620","volume":"281","author":"SI Suga","year":"2001","unstructured":"Suga, S. I. et al. Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. Am. J. Physiol. Renal Physiol 281, F620\u2013F629 (2001).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1681\/ASN.2007030261","volume":"19","author":"S Reungjui","year":"2008","unstructured":"Reungjui, S. et al. Hypokalemic nephropathy is associated with impaired angiogenesis. J. Am. Soc. Nephrol. 19, 125\u2013134 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR62","doi-asserted-by":"publisher","first-page":"F899","DOI":"10.1152\/ajprenal.00175.2024","volume":"327","author":"A Wu","year":"2024","unstructured":"Wu, A. et al. Macrophage SPAK deletion limits a low potassium-induced kidney inflammatory program. Am. J. Physiol. Renal Physiol 327, F899\u2013F909 (2024).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR63","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.ajpath.2025.08.010","volume":"195","author":"S Komori","year":"2025","unstructured":"Komori, S. et al. Low potassium triggers tubular epithelial NLR family pyrin domain containing 3\/apoptosis-associated speck-like protein-containing a CARD-driven kidney inflammation independently of inflammasomes. Am. J. Pathol. 195, 2336\u20132355 (2025).","journal-title":"Am. J. Pathol."},{"key":"1053_CR64","doi-asserted-by":"publisher","first-page":"F748","DOI":"10.1152\/ajprenal.00655.2020","volume":"320","author":"A-Q Lama","year":"2021","unstructured":"Lama, A.-Q., Grimm, P. R., Ava, M. Z. & Paul, A. W. Rapid development of vasopressin resistance in dietary K+ deficiency. Am. J. Physiol. Renal Physiol. 320, F748\u2013F760 (2021).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1053_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/srep18311","volume":"5","author":"S Khositseth","year":"2015","unstructured":"Khositseth, S. et al. Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus. Sci. Rep. 5, 18311 (2015).","journal-title":"Sci. Rep."},{"key":"1053_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61882-7","volume":"10","author":"A Iervolino","year":"2020","unstructured":"Iervolino, A. et al. Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway. Sci. Rep. 10, 5708 (2020).","journal-title":"Sci. Rep."},{"key":"1053_CR67","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1172\/JCI104448","volume":"40","author":"ME Rubini","year":"1961","unstructured":"Rubini, M. E. Water excretion in potassium-deficient man. J. Clin. Invest. 40, 2215\u20132224 (1961).","journal-title":"J. Clin. Invest."},{"key":"1053_CR68","first-page":"281","volume":"18","author":"WL Addison","year":"1928","unstructured":"Addison, W. L. The use of sodium chloride, potassium chloride, sodium bromide, and potassium bromide in cases of arterial hypertension which are amenable to potassium chloride. Can. Med. Assoc. J. 18, 281\u2013285 (1928).","journal-title":"Can. Med. Assoc. J."},{"key":"1053_CR69","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","volume":"297","author":"Intersalt Cooperative Research Group","year":"1988","unstructured":"Intersalt Cooperative Research Group Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 297, 319\u2013328 (1988).","journal-title":"BMJ"},{"key":"1053_CR70","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","volume":"336","author":"LJ Appel","year":"1997","unstructured":"Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336, 1117\u20131124 (1997).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR71","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/archinternmed.2010.284","volume":"170","author":"LA van Mierlo","year":"2010","unstructured":"van Mierlo, L. A., Greyling, A., Zock, P. L., Kok, F. J. & Geleijnse, J. M. Suboptimal potassium intake and potential impact on population blood pressure. Arch. Intern. Med. 170, 1501\u20131502 (2010).","journal-title":"Arch. Intern. Med."},{"key":"1053_CR72","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMoa1311889","volume":"371","author":"M O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell, M. et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N. Engl. J. Med. 371, 612\u2013623 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1378","volume":"346","author":"NJ Aburto","year":"2013","unstructured":"Aburto, N. J. et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 346, f1378 (2013).","journal-title":"BMJ"},{"key":"1053_CR74","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/eurheartj\/ehac313","volume":"43","author":"RD Wouda","year":"2022","unstructured":"Wouda, R. D. et al. Sex-specific associations between potassium intake, blood pressure, and cardiovascular outcomes: the EPIC-Norfolk study. Eur. Heart J. 43, 2867\u20132875 (2022).","journal-title":"Eur. Heart J."},{"key":"1053_CR75","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2109794","volume":"386","author":"Y Ma","year":"2022","unstructured":"Ma, Y. et al. 24-Hour urinary sodium and potassium excretion and cardiovascular risk. N. Engl. J. Med. 386, 252\u2013263 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR76","first-page":"2229","volume":"306","author":"MJ O\u2019Donnell","year":"2011","unstructured":"O\u2019Donnell, M. J. et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306, 2229\u20132238 (2011).","journal-title":"JAMA"},{"key":"1053_CR77","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/HYPERTENSIONAHA.123.19487","volume":"81","author":"R Little","year":"2024","unstructured":"Little, R. & Ellison, D. H. Modifying dietary sodium and potassium intake: an end to the \u2018salt wars\u2019? Hypertension 81, 415\u2013425 (2024).","journal-title":"Hypertension"},{"key":"1053_CR78","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41591-023-02286-8","volume":"29","author":"Y Yuan","year":"2023","unstructured":"Yuan, Y. et al. Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial. Nat. Med. 29, 973\u2013981 (2023).","journal-title":"Nat. Med."},{"key":"1053_CR79","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41591-020-0754-2","volume":"26","author":"A Bernabe-Ortiz","year":"2020","unstructured":"Bernabe-Ortiz, A. et al. Effect of salt substitution on community-wide blood pressure and hypertension incidence. Nat. Med. 26, 374\u2013378 (2020).","journal-title":"Nat. Med."},{"key":"1053_CR80","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","volume":"385","author":"B Neal","year":"2021","unstructured":"Neal, B. et al. Effect of salt substitution on cardiovascular events and death. N. Engl. J. Med. 385, 1067\u20131077 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR81","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/ajcn\/nqab054","volume":"114","author":"J Yu","year":"2021","unstructured":"Yu, J. et al. Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 114, 185\u2013193 (2021).","journal-title":"Am. J. Clin. Nutr."},{"key":"1053_CR82","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.122.059573","volume":"145","author":"KC Li","year":"2022","unstructured":"Li, K. C. et al. Cost-effectiveness of a household salt substitution intervention: findings from 20 995 participants of the Salt Substitute and Stroke Study. Circulation 145, 1534\u20131541 (2022).","journal-title":"Circulation"},{"key":"1053_CR83","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.55564","volume":"7","author":"X Lai","year":"2024","unstructured":"Lai, X. et al. Cost-effectiveness of salt substitute and salt supply restriction in eldercare facilities: the Decide-Salt cluster randomized clinical trial. JAMA Netw. Open. 7, e2355564 (2024).","journal-title":"JAMA Netw. Open."},{"key":"1053_CR84","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41371-024-00896-4","volume":"38","author":"L Huang","year":"2024","unstructured":"Huang, L. et al. The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study. J. Hum. Hypertens. 38, 298\u2013306 (2024).","journal-title":"J. Hum. Hypertens."},{"key":"1053_CR85","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41581-022-00599-4","volume":"18","author":"EJ Hoorn","year":"2022","unstructured":"Hoorn, E. J., Marklund, M. & Wu, J. H. Y. Salt substitution: opportunities and challenges for nephrology. Nat. Rev. Nephrol. 18, 539\u2013540 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1053_CR86","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m824","volume":"369","author":"M Marklund","year":"2020","unstructured":"Marklund, M. et al. Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study. BMJ 369, m824 (2020).","journal-title":"BMJ"},{"key":"1053_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2024.100432","volume":"26","author":"LN Aminde","year":"2024","unstructured":"Aminde, L. N. et al. Cost-effectiveness analysis of low-sodium potassium-rich salt substitutes in Indonesia: an equity modelling study. Lancet Reg. Health Southeast. Asia 26, 100432 (2024).","journal-title":"Lancet Reg. Health Southeast. Asia"},{"key":"1053_CR88","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1136\/heartjnl-2022-321332","volume":"108","author":"X Yin","year":"2022","unstructured":"Yin, X. et al. Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart 108, 1608\u20131615 (2022).","journal-title":"Heart"},{"key":"1053_CR89","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.156437","volume":"8","author":"R Little","year":"2023","unstructured":"Little, R. et al. Dissociation of sodium-chloride cotransporter expression and blood pressure during chronic high dietary potassium supplementation. JCI Insight 8, e156437 (2023).","journal-title":"JCI Insight"},{"key":"1053_CR90","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/ndt\/gfad220","volume":"39","author":"M Gritter","year":"2024","unstructured":"Gritter, M. et al. Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intake. Nephrol. Dial. Transpl. 39, 795\u2013807 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1053_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1681\/ASN.V114625","volume":"11","author":"HN Ibrahim","year":"2000","unstructured":"Ibrahim, H. N. & Hostetter, T. H. Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model. J. Am. Soc. Nephrol. 11, 625\u2013631 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR92","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1113\/jphysiol.2013.266924","volume":"592","author":"H Vitzthum","year":"2014","unstructured":"Vitzthum, H. et al. Functional coupling of renal K+ and Na+ handling causes high blood pressure in Na+ replete mice. J. Physiol. 592, 1139\u20131157 (2014).","journal-title":"J. Physiol."},{"key":"1053_CR93","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015719","volume":"9","author":"T Filippini","year":"2020","unstructured":"Filippini, T. et al. Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials. J. Am. Heart Assoc. 9, e015719 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"1053_CR94","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004210","volume":"5","author":"M Vinceti","year":"2016","unstructured":"Vinceti, M. et al. Meta-analysis of potassium intake and the risk of stroke. J. Am. Heart Assoc. 5, e004210 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"1053_CR95","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2011.1967","volume":"307","author":"A Goyal","year":"2012","unstructured":"Goyal, A. et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA 307, 157\u2013164 (2012).","journal-title":"JAMA"},{"key":"1053_CR96","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2215\/CJN.05850809","volume":"5","author":"S Korgaonkar","year":"2010","unstructured":"Korgaonkar, S. et al. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin. J. Am. Soc. Nephrol. 5, 762\u2013769 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR97","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","volume":"39","author":"CP Kovesdy","year":"2018","unstructured":"Kovesdy, C. P. et al. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. Eur. Heart J. 39, 1535\u20131542 (2018).","journal-title":"Eur. Heart J."},{"key":"1053_CR98","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa2509542","volume":"393","author":"C J\u00f8ns","year":"2025","unstructured":"J\u00f8ns, C. et al. Increasing the potassium level in patients at high risk for ventricular arrhythmias. N. Engl. J. Med. 393, 1979\u20131989 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR99","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.109.899526","volume":"3","author":"CB Bowling","year":"2010","unstructured":"Bowling, C. B. et al. Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ. Heart Fail. 3, 253\u2013260 (2010).","journal-title":"Circ. Heart Fail."},{"key":"1053_CR100","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2215\/CJN.01730215","volume":"11","author":"J Luo","year":"2016","unstructured":"Luo, J., Brunelli, S. M., Jensen, D. E. & Yang, A. Association between serum potassium and outcomes in patients with reduced kidney function. Clin. J. Am. Soc. Nephrol. 11, 90\u2013100 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.ajkd.2023.03.008","volume":"82","author":"ENM de Rooij","year":"2023","unstructured":"de Rooij, E. N. M. et al. Serum potassium and risk of death or kidney replacement therapy in older people with CKD stages 4-5: eight-year follow-up. Am. J. Kidney Dis. 82, 257\u2013266.e1 (2023).","journal-title":"Am. J. Kidney Dis."},{"key":"1053_CR102","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1373\/49.1.190","volume":"49","author":"DK Wysowski","year":"2003","unstructured":"Wysowski, D. K., Kornegay, C., Nourjah, P. & Trontell, A. Sex and age differences in serum potassium in the United States. Clin. Chem. 49, 190\u2013192 (2003).","journal-title":"Clin. Chem."},{"key":"1053_CR103","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41371-019-0224-9","volume":"34","author":"M Li","year":"2020","unstructured":"Li, M. et al. Association between blood pressure and dietary intakes of sodium and potassium among US adults using quantile regression analysis NHANES 2007-2014. J. Hum. Hypertens. 34, 346\u2013354 (2020).","journal-title":"J. Hum. Hypertens."},{"key":"1053_CR104","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1681\/ASN.2017030295","volume":"28","author":"LC Veiras","year":"2017","unstructured":"Veiras, L. C. et al. Sexual dimorphic pattern of renal transporters and electrolyte homeostasis. J. Am. Soc. Nephrol. 28, 3504\u20133517 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR105","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/0021-9681(87)90183-4","volume":"40","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1987","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents Urinary and serum electrolytes in untreated black and white hypertensives. J. Chronic Dis. 40, 839\u2013847 (1987).","journal-title":"J. Chronic Dis."},{"key":"1053_CR106","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.1997.03540440058033","volume":"277","author":"PK Whelton","year":"1997","unstructured":"Whelton, P. K. et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277, 1624\u20131632 (1997).","journal-title":"JAMA"},{"key":"1053_CR107","first-page":"c8","volume":"120","author":"J Hayes","year":"2012","unstructured":"Hayes, J. et al. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin. Pract. 120, c8\u2013c16 (2012).","journal-title":"Nephron Clin. Pract."},{"key":"1053_CR108","doi-asserted-by":"publisher","first-page":"H1903","DOI":"10.1152\/ajpheart.00980.2020","volume":"320","author":"TW Kurtz","year":"2021","unstructured":"Kurtz, T. W., DiCarlo, S. E., Pravenec, M. & Morris, R. C. Jr No evidence of racial disparities in blood pressure salt sensitivity when potassium intake exceeds levels recommended in the US dietary guidelines. Am. J. Physiol. Heart Circ. Physiol 320, H1903\u2013H1918 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"1053_CR109","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"1053_CR110","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2215\/CJN.0000000000000228","volume":"18","author":"RD Wouda","year":"2023","unstructured":"Wouda, R. D. et al. Kaliuresis and intracellular uptake of potassium with potassium citrate and potassium chloride supplements: a randomized controlled trial. Clin. J. Am. Soc. Nephrol. 18, 1260\u20131271 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR111","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2215\/CJN.0000000000000294","volume":"18","author":"RW Hunter","year":"2023","unstructured":"Hunter, R. W. & Bailey, M. A. Horses for courses: what is the best oral potassium supplementation strategy? Clin. J. Am. Soc. Nephrol. 18, 1250\u20131253 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR112","doi-asserted-by":"publisher","first-page":"F377","DOI":"10.1152\/ajprenal.00193.2023","volume":"325","author":"L Al-Qusairi","year":"2023","unstructured":"Al-Qusairi, L. et al. Dietary anions control potassium excretion: it is more than a poorly absorbable anion effect. Am. J. Physiol. Renal Physiol 325, F377\u2013F393 (2023).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR113","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1172\/JCI108958","volume":"61","author":"RA DeFronzo","year":"1978","unstructured":"DeFronzo, R. A. et al. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings. J. Clin. Invest. 61, 472\u2013479 (1978).","journal-title":"J. Clin. Invest."},{"key":"1053_CR114","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s00467-021-05365-5","volume":"37","author":"A El Amouri","year":"2022","unstructured":"El Amouri, A. et al. Potassium and fiber: a controversial couple in the nutritional management of children with chronic kidney disease. Pediatr. Nephrol. 37, 1657\u20131665 (2022).","journal-title":"Pediatr. Nephrol."},{"key":"1053_CR115","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/ndt\/gfaa232","volume":"36","author":"CI Ramos","year":"2021","unstructured":"Ramos, C. I. et al. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease? Nephrol. Dial. Transpl. 36, 2049\u20132057 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1053_CR116","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/ndt\/gfad015","volume":"38","author":"M Granal","year":"2023","unstructured":"Granal, M., Fouque, D., Ducher, M. & Fauvel, J. P. Factors associated with kalemia in renal disease. Nephrol. Dial. Transpl. 38, 2067\u20132076 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1053_CR117","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2215\/CJN.08360621","volume":"16","author":"A Bernier-Jean","year":"2021","unstructured":"Bernier-Jean, A. et al. Dietary potassium intake and all-cause mortality in adults treated with hemodialysis. Clin. J. Am. Soc. Nephrol. 16, 1851\u20131861 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR118","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011716","volume":"6","author":"FP Cappuccio","year":"2016","unstructured":"Cappuccio, F. P., Buchanan, L. A., Ji, C., Siani, A. & Miller, M. A. Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine. BMJ Open. 6, e011716 (2016).","journal-title":"BMJ Open."},{"key":"1053_CR119","volume":"8","author":"A Brand","year":"2022","unstructured":"Brand, A., Visser, M. E., Schoonees, A. & Naude, C. E. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women. Cochrane Database Syst. Rev. 8, CD015207 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1053_CR120","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077249","volume":"13","author":"Y Yuan","year":"2023","unstructured":"Yuan, Y. et al. Association of serum potassium level with dietary potassium intake in Chinese older adults: a multicentre, cross-sectional survey. BMJ Open. 13, e077249 (2023).","journal-title":"BMJ Open."},{"key":"1053_CR121","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ekir.2022.12.005","volume":"8","author":"S Ogata","year":"2023","unstructured":"Ogata, S. et al. Association between dietary potassium intake estimated from multiple 24-hour urine collections and serum potassium in patients with CKD. Kidney Int. Rep. 8, 584\u2013595 (2023).","journal-title":"Kidney Int. Rep."},{"key":"1053_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082678","volume":"13","author":"S Turban","year":"2021","unstructured":"Turban, S. et al. Randomized trial on the effects of dietary potassium on blood pressure and serum potassium levels in adults with chronic kidney disease. Nutrients 13, 2678 (2021).","journal-title":"Nutrients"},{"key":"1053_CR123","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1681\/ASN.2022020147","volume":"33","author":"M Gritter","year":"2022","unstructured":"Gritter, M. et al. Effects of short-term potassium chloride supplementation in patients with CKD. J. Am. Soc. Nephrol. 33, 1779\u20131789 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR124","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2215\/CJN.07821109","volume":"5","author":"MR Weir","year":"2010","unstructured":"Weir, M. R. & Rolfe, M. Potassium homeostasis and renin\u2013angiotensin\u2013aldosterone system inhibitors. Clin. J. Am. Soc. Nephrol. 5, 531\u2013548 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR125","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/ki.2014.214","volume":"86","author":"A Smyth","year":"2014","unstructured":"Smyth, A. et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int. 86, 1205\u20131212 (2014).","journal-title":"Kidney Int."},{"key":"1053_CR126","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.kint.2021.10.030","volume":"101","author":"S Ogata","year":"2022","unstructured":"Ogata, S. et al. A multiple 24-hour urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease. Kidney Int. 101, 164\u2013173 (2022).","journal-title":"Kidney Int."},{"key":"1053_CR127","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3945\/ajcn.116.134056","volume":"104","author":"MF Eisenga","year":"2016","unstructured":"Eisenga, M. F. et al. Urinary potassium excretion, renal ammoniagenesis, and risk of graft failure and mortality in renal transplant recipients. Am. J. Clin. Nutr. 104, 1703\u20131711 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"1053_CR128","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.2215\/CJN.00980115","volume":"10","author":"S Araki","year":"2015","unstructured":"Araki, S. et al. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin. J. Am. Soc. Nephrol. 10, 2152\u20132158 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR129","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1016\/j.clnu.2020.03.026","volume":"39","author":"RHG Olde Engberink","year":"2020","unstructured":"Olde Engberink, R. H. G., van den Born, B. H., Peters-Sengers, H., Vogt, L. & onsortium, K. Long-term potassium intake and associated renal and cardiovascular outcomes in the clinical setting. Clin. Nutr. 39, 3671\u20133676 (2020).","journal-title":"Clin. Nutr."},{"key":"1053_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152306","volume":"11","author":"T Nagata","year":"2016","unstructured":"Nagata, T. et al. Association between 24h urinary sodium and potassium excretion and estimated glomerular filtration rate (eGFR) decline or death in patients with diabetes mellitus and eGFR more than 30 ml\/min\/1.73m2. PLoS ONE 11, e0152306 (2016).","journal-title":"PLoS ONE"},{"key":"1053_CR131","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ajcnut.2024.02.004","volume":"119","author":"HJ Kim","year":"2024","unstructured":"Kim, H. J. et al. Higher potassium intake is associated with a lower risk of chronic kidney disease: population-based prospective study. Am. J. Clin. Nutr. 119, 1044\u20131051 (2024).","journal-title":"Am. J. Clin. Nutr."},{"key":"1053_CR132","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.mayocp.2022.04.017","volume":"97","author":"YS Joo","year":"2022","unstructured":"Joo, Y. S. et al. Urinary sodium-to-potassium ratio and incident chronic kidney disease: results from the Korean Genome and Epidemiology Study. Mayo Clin. Proc. 97, 2259\u20132270 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"1053_CR133","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2215\/CJN.07820618","volume":"14","author":"HW Kim","year":"2019","unstructured":"Kim, H. W. et al. Urinary potassium excretion and progression of CKD. Clin. J. Am. Soc. Nephrol. 14, 330\u2013340 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR134","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/ndt\/gfae277","volume":"40","author":"T Suenaga","year":"2025","unstructured":"Suenaga, T. et al. Estimated potassium intake and the progression of chronic kidney disease. Nephrol. Dial. Transplant. 40, 1362\u20131373 (2025).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1053_CR135","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.ajkd.2016.03.431","volume":"69","author":"AK Leonberg-Yoo","year":"2017","unstructured":"Leonberg-Yoo, A. K., Tighiouart, H., Levey, A. S., Beck, G. J. & Sarnak, M. J. Urine potassium excretion, kidney failure, and mortality in CKD. Am. J. Kidney Dis. 69, 341\u2013349 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"1053_CR136","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1681\/ASN.2015010022","volume":"27","author":"J He","year":"2016","unstructured":"He, J. et al. Urinary sodium and potassium excretion and CKD progression. J. Am. Soc. Nephrol. 27, 1202\u20131212 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR137","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2215\/CJN.02680322","volume":"17","author":"TO Ilori","year":"2022","unstructured":"Ilori, T. O. et al. Apolipoprotein L1 genotypes and the association of urinary potassium excretion with CKD progression. Clin. J. Am. Soc. Nephrol. 17, 1477\u20131486 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR138","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1073\/pnas.1522913113","volume":"113","author":"OA Olabisi","year":"2016","unstructured":"Olabisi, O. A. et al. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc. Natl Acad. Sci. USA 113, 830\u2013837 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1053_CR139","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf238","author":"RD Wouda","year":"2025","unstructured":"Wouda, R. D. et al. Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease: a randomized controlled trial. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfaf238 (2025).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1053_CR140","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1093\/ckj\/sfab031","volume":"14","author":"RD Wouda","year":"2021","unstructured":"Wouda, R. D. et al. Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD. Clin. Kidney J. 14, 2170\u20132176 (2021).","journal-title":"Clin. Kidney J."},{"key":"1053_CR141","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1681\/ASN.2009111110","volume":"21","author":"P Sun","year":"2010","unstructured":"Sun, P. et al. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC. J. Am. Soc. Nephrol. 21, 1667\u20131677 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR142","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/ASN.0000000000000420","volume":"35","author":"DL Ralph","year":"2024","unstructured":"Ralph, D. L. et al. Potassium-alkali-enriched diet, hypertension, and proteinuria following uninephrectomy. J. Am. Soc. Nephrol. 35, 1330\u20131350 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067140","volume":"8","author":"HH Wang","year":"2013","unstructured":"Wang, H. H. et al. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. PLoS ONE 8, e67140 (2013).","journal-title":"PLoS ONE"},{"key":"1053_CR144","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.34067\/KID.0000000000000541","volume":"5","author":"A Agiro","year":"2024","unstructured":"Agiro, A. et al. Hyperkalemia and risk of CKD progression: a propensity score-matched analysis. Kidney360 5, 1824\u20131834 (2024).","journal-title":"Kidney360"},{"key":"1053_CR145","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2215\/CJN.0000000675","volume":"20","author":"L Bernard","year":"2025","unstructured":"Bernard, L. et al. Serum metabolomic markers of dietary potassium and risk of CKD. Clin. J. Am. Soc. Nephrol. 20, 642\u2013651 (2025).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR146","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1681\/ASN.2010010079","volume":"21","author":"RH Sterns","year":"2010","unstructured":"Sterns, R. H., Rojas, M., Bernstein, P. & Chennupati, S. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J. Am. Soc. Nephrol. 21, 733\u2013735 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR147","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamainternmed.2019.0631","volume":"179","author":"JA Noel","year":"2019","unstructured":"Noel, J. A. et al. Risk of hospitalization for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients of advanced age. JAMA Intern. Med. 179, 1025\u20131033 (2019).","journal-title":"JAMA Intern. Med."},{"key":"1053_CR148","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1410853","volume":"372","author":"MR Weir","year":"2015","unstructured":"Weir, M. R. et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N. Engl. J. Med. 372, 211\u2013221 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR149","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1411487","volume":"372","author":"DK Packham","year":"2015","unstructured":"Packham, D. K. et al. Sodium zirconium cyclosilicate in hyperkalemia. N. Engl. J. Med. 372, 222\u2013231 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1053_CR150","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","volume":"394","author":"R Agarwal","year":"2019","unstructured":"Agarwal, R. et al. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 394, 1540\u20131550 (2019).","journal-title":"Lancet"},{"key":"1053_CR151","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/ehf2.15171","volume":"12","author":"CV Pollack Jr.","year":"2025","unstructured":"Pollack, C. V. Jr. et al. Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode. ESC Heart Fail. 12, 1776\u20131785 (2025).","journal-title":"ESC Heart Fail."},{"key":"1053_CR152","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1681\/ASN.2020050682","volume":"32","author":"EL Fu","year":"2021","unstructured":"Fu, E. L. et al. Stopping renin\u2013angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study. J. Am. Soc. Nephrol. 32, 424\u2013435 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1053_CR153","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.ajkd.2022.01.002","volume":"80","author":"SJ Leon","year":"2022","unstructured":"Leon, S. J. et al. Hyperkalemia-related discontinuation of renin-angiotensin\u2013aldosterone system inhibitors and clinical outcomes in CKD: a population-based cohort study. Am. J. Kidney Dis. 80, 164\u2013173.e1 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"1053_CR154","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/ejhf.2287","volume":"23","author":"M Trevisan","year":"2021","unstructured":"Trevisan, M. et al. Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care. Eur. J. Heart Fail. 23, 1698\u20131707 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"1053_CR155","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2215\/CJN.12651018","volume":"14","author":"BS Spinowitz","year":"2019","unstructured":"Spinowitz, B. S. et al. Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study. Clin. J. Am. Soc. Nephrol. 14, 798\u2013809 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR156","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2024.05.079","volume":"84","author":"B Pitt","year":"2024","unstructured":"Pitt, B. et al. Patiromer facilitates angiotensin inhibitor and mineralocorticoid antagonist therapies in patients with heart failure and hyperkalemia. J. Am. Coll. Cardiol. 84, 1295\u20131308 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1053_CR157","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jacc.2024.11.014","volume":"85","author":"MN Kosiborod","year":"2025","unstructured":"Kosiborod, M. N. et al. Sodium zirconium cyclosilicate for management of hyperkalemia during spironolactone optimization in patients with heart failure. J. Am. Coll. Cardiol. 85, 971\u2013984 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1053_CR158","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.kint.2016.04.019","volume":"90","author":"MR Weir","year":"2016","unstructured":"Weir, M. R. et al. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin\u2013angiotensin system inhibitors. Kidney Int. 90, 696\u2013704 (2016).","journal-title":"Kidney Int."},{"key":"1053_CR159","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/ndt\/gfaa158","volume":"36","author":"SD Roger","year":"2021","unstructured":"Roger, S. D. et al. Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials. Nephrol. Dial. Transpl. 36, 871\u2013883 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1053_CR160","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ehf2.14588","volume":"11","author":"M Abuelazm","year":"2024","unstructured":"Abuelazm, M. et al. The efficacy and safety of new potassium binders on renin\u2013angiotensin\u2013aldosterone system inhibitor optimization in heart failure patients: a systematic review and meta-analysis. ESC Heart Fail. 11, 28\u201343 (2024).","journal-title":"ESC Heart Fail."},{"key":"1053_CR161","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","volume":"43","author":"J Butler","year":"2022","unstructured":"Butler, J. et al. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the Diamond trial. Eur. Heart J. 43, 4362\u20134373 (2022).","journal-title":"Eur. Heart J."},{"key":"1053_CR162","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1053\/j.jrn.2022.12.003","volume":"33","author":"K Sumida","year":"2023","unstructured":"Sumida, K. et al. New insights into dietary approaches to potassium management in chronic kidney disease. J. Ren. Nutr. 33, S6\u2013S12 (2023).","journal-title":"J. Ren. Nutr."},{"key":"1053_CR163","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1053\/j.ajkd.2023.09.020","volume":"83","author":"S Amir","year":"2024","unstructured":"Amir, S. et al. Adherence to plant-based diets and risk of CKD progression and all-cause mortality: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am. J. Kidney Dis. 83, 624\u2013635 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1053_CR164","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012865","volume":"8","author":"H Kim","year":"2019","unstructured":"Kim, H. et al. Plant-based diets are associated with a lower risk of incident cardiovascular disease, cardiovascular disease mortality, and all-cause mortality in a general population of middle-aged adults. J. Am. Heart Assoc. 8, e012865 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"1053_CR165","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajcnut.2024.06.025","volume":"120","author":"CM Avesani","year":"2024","unstructured":"Avesani, C. M. et al. Plant-based diet in hyperkalemic chronic kidney disease patients receiving sodium zirconium cyclosilicate: a feasibility clinical trial. Am. J. Clin. Nutr. 120, 719\u2013726 (2024).","journal-title":"Am. J. Clin. Nutr."},{"key":"1053_CR166","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2215\/CJN.09660721","volume":"17","author":"DE St-Jules","year":"2022","unstructured":"St-Jules, D. E., Clegg, D. J., Palmer, B. F. & Carrero, J. J. Can novel potassium binders liberate people with chronic kidney disease from the low-potassium diet? A cautionary tale. Clin. J. Am. Soc. Nephrol. 17, 467\u2013472 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR167","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1161\/CIRCULATIONAHA.121.057736","volume":"145","author":"BL Neuen","year":"2022","unstructured":"Neuen, B. L. et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation 145, 1460\u20131470 (2022).","journal-title":"Circulation"},{"key":"1053_CR168","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078483","volume":"385","author":"EL Fu","year":"2024","unstructured":"Fu, E. L. et al. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study. BMJ 385, e078483 (2024).","journal-title":"BMJ"},{"key":"1053_CR169","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2215\/CJN.0000000000000300","volume":"19","author":"BF Palmer","year":"2024","unstructured":"Palmer, B. F. & Clegg, D. J. SGLT2 inhibition and kidney potassium homeostasis. Clin. J. Am. Soc. Nephrol. 19, 399\u2013405 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1053_CR170","doi-asserted-by":"publisher","first-page":"F231","DOI":"10.1152\/ajprenal.00432.2018","volume":"316","author":"L Tonneijck","year":"2019","unstructured":"Tonneijck, L. et al. Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus. Am. J. Physiol. Renal Physiol 316, F231\u2013F240 (2019).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"1053_CR171","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/ckj\/sfac234","volume":"16","author":"R Agarwal","year":"2023","unstructured":"Agarwal, R. et al. A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clin. Kidney J. 16, 293\u2013302 (2023).","journal-title":"Clin. Kidney J."},{"key":"1053_CR172","unstructured":"World Health Organization. Use of Lower-Sodium Salt Substitutes: WHO Guideline (WHO, 2025)."},{"key":"1053_CR173","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy, J. W. et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur. Heart J. 45, 3912\u20134018 (2024).","journal-title":"Eur. Heart J."},{"key":"1053_CR174","doi-asserted-by":"publisher","first-page":"e1509","DOI":"10.1016\/S2214-109X(25)00235-9","volume":"13","author":"K Trieu","year":"2025","unstructured":"Trieu, K. et al. Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health. Lancet Glob. Health 13, e1509\u2013e1511 (2025).","journal-title":"Lancet Glob. Health"},{"key":"1053_CR175","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.kint.2016.09.001","volume":"91","author":"W Shoda","year":"2017","unstructured":"Shoda, W. et al. Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake. Kidney Int. 91, 402\u2013411 (2017).","journal-title":"Kidney Int."},{"key":"1053_CR176","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1172\/JCI80304","volume":"126","author":"F Grahammer","year":"2016","unstructured":"Grahammer, F. et al. mTORC2 critically regulates renal potassium handling. J. Clin. Invest. 126, 1773\u20131782 (2016).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01053-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01053-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01053-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:02:04Z","timestamp":1776859324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01053-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":176,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01053-5","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"9 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.J.H. is a contributor to UpToDate. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}